Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
13-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #88
advertisement
Experimental Eye Research
20
Showing records 1 to 20 |
Display all abstracts in
Experimental Eye Research
46397
Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies
Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA
Experimental Eye Research
2011; 93: 204-212
46411
Glaucomatous cupping of the lamina cribrosa: A review of the evidence for active progressive remodeling as a mechanism
Crawford Downs J; Roberts MD; Sigal IA
Experimental Eye Research
2011; 93: 133-140
46391
A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma
Burgoyne CF
Experimental Eye Research
2011; 93: 120-132
46396
What has gene expression profiling taught us about glaucoma?
Yang Z; Zack DJ
Experimental Eye Research
2011; 93: 191-195
46532
Molecular genetics in glaucoma
Liu Y; Allingham RR
Experimental Eye Research
2011;
46384
The pathogenic role of transforming growth factor-β2 in glaucomatous damage to the optic nerve head
Fuchshofer R
Experimental Eye Research
2011; 93: 165-169
46523
Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma
Li A; Zhang X; Zheng D; Ge J; Laties AM; Mitchell CH
Experimental Eye Research
2011;
46526
Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells
Tovar-Vidales T; Clark AF; Wordinger RJ
Experimental Eye Research
2011;
46394
Endothelin, astrocytes and glaucoma
Prasanna G; Krishnamoorthy R; Yorio T
Experimental Eye Research
2011; 93: 170-177
46412
Pathophysiology of human glaucomatous optic nerve damage: Insights from rodent models of glaucoma
Morrison JC; Cepurna WO; Guo Y; Johnson EC
Experimental Eye Research
2011; 93: 156-164
46395
The case for autoimmunity in glaucoma
Wax MB
Experimental Eye Research
2011; 93: 187-190
46407
The immune response in glaucoma: A perspective on the roles of oxidative stress
Tezel G
Experimental Eye Research
2011; 93: 178-186
46531
Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats
Dogan S; Unal M; Ozturk N; Yargicoglu P; Cort A; Spasojevic I; Batinic-Haberle I; Aslan M
Experimental Eye Research
2011;
46527
Retinal proliferation response in the buphthalmic zebrafish, bugeye
Sherpa T; Hunter SS; Frey RA; Robison BD; Stenkamp DL
Experimental Eye Research
2011;
46393
The complex interaction between ocular perfusion pressure and ocular blood flow -Relevance for glaucoma
Schmidl D; Garhofer G; Schmetterer L
Experimental Eye Research
2011; 93: 141-155
46524
Optical coherence tomography (OCT) measurements in black and white children with large cup-to-disc ratios
El-Dairi M; Holgado S; Asrani S; Freedman SF
Experimental Eye Research
2011;
46379
A novel free radical scavenger rescues retinal cells in vivo
O'Driscoll C; Doonan F; Sanvicens N; Messeguer A; Cotter TG
Experimental Eye Research
2011; 93: 65-74
46405
Neurotrophic factor delivery as a protective treatment for glaucoma
Johnson TV; Bull ND; Martin KR
Experimental Eye Research
2011; 93: 196-203
46380
Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers
Gerometta R; Alvarez LJ; Candia OA
Experimental Eye Research
2011; 93: 103-107
46528
A model to measure lymphatic drainage from the eye
Kim M; Johnston MG; Gupta N; Moore S; Yucel YH
Experimental Eye Research
2011; 93: 586-591
Issue
13-3
Table of Contents
Editor's Selection
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement